Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07435636
Modulation of Stem Cell Differentiation in Individuals With High Risk Clonal Haematopoiesis (MOSAIC)
A Multi-centre, Double-blind, Placebo-controlled Randomised Phase II Trial to Evaluate the Effect of Low Dose Decitabine and Tetrahydrouridine in Individuals With High-risk Clonal Haematopoiesis
Sponsor: Australian National University
Conditions
CCUS Clonal Cytopenia of Undetermined Significance Clonal Cytopenia of Uncertain Significance Clonal Hematopoiesis
Updated 1 time since 2026 Last updated: Feb 23, 2026 Started: Apr 13, 2026 Primary completion: Apr 14, 2030 Completion: Oct 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on CCUS Clonal Cytopenia of Undetermined Significance and Clonal Cytopenia of Uncertain Significance, this trial is actively recruiting participants. The trial is conducted by Australian National University and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Australian National University
- Clinical Hub for Interventional Research (CHOIR)
- Medical Research Future Fund
- The University of New South Wales
- Treebough Therapies
- University of Auckland, New Zealand
Data source: Clinical Hub for Interventional Research (CHOIR)
For direct contact, visit the study record on ClinicalTrials.gov .